Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-08-23A Multicenter, Randomized, Vehicle-controlled, Efficacy and Safety Study of CD2027 3µg/g Oily Spray Applied Twice Daily for 8 Weeks in Subjects With Plaque-type Psoriasis
-
CLINICAL_TRIALS study record update · 2022-08-05Proton Pump Inhibitors Use in Patients With Psoriasis
-
CLINICAL_TRIALS study record update · 2022-07-29A Comparison Between Clobetasol Propionate (Clobex®) Spray and Clobetasol Propionate (Olux®) Foam With Regard to Efficacy, Safety, Preference and Duration of Response in Stable Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2022-07-29Phase 4 Open-Label Multicenter Community-based 4-Wk Trial to Assess Efficacy, Tolerance to Tx & Patient Satisfaction w/ CLOBEX® Spray When Used as Mono- or Add-on Therapy to Existing Systemic/Topical Agents for Tx of Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2022-07-29Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): a Cross-sectional Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-07-28The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
-
CLINICAL_TRIALS study record update · 2022-07-15A Canadian Phase IV, Multicenter, Single-Arm Study To Evaluate the Effectiveness of Treatment With Brodalumab (SILIQ) in Psoriasis Patients With Inadequate Response to Their Current Biologic Agent Regimen
-
CLINICAL_TRIALS study record update · 2022-07-08Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2022-07-01Characteristics, Treatment Patterns, and Treatment Satisfaction Among Psoriasis Patients Treated With Cosentyx (Secukinumab)
-
CLINICAL_TRIALS study record update · 2022-06-29A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL-GROUP, DOSE RANGING STUDY TO ASSESS EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06700841 TOPICAL CREAM APPLIED ONCE OR TWICE DAILY FOR 12 WEEKS IN PARTICIPANTS WITH MILD TO MODERATE CHRONIC PLAQUE PSORIASIS
-
CLINICAL_TRIALS study record update · 2022-06-22Evaluation of the Effect of Narrowband Ultraviolet B Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis.
-
CLINICAL_TRIALS study record update · 2022-06-21Impact of Non-surgical Periodontal Therapy in the Management of Plaque Psoriasis. A Randomised Controlled Trial.
-
CLINICAL_TRIALS study record update · 2022-06-06Patient Preference for Treatment of Moderate-To-Severe Psoriasis in Japan
-
CLINICAL_TRIALS study record update · 2022-06-03Treatment Patterns and Outcomes Study for Psoriasis (PSO) in Japan
-
CLINICAL_TRIALS study record update · 2022-06-02Phase II Evaluation of Safety, Tolerability, and Efficacy of BI 730357 in Patients With Moderate-to-severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2022-06-02Evaluation of the Effect of Acitretin Versus Narrowband Ultraviolet B on Serum Neopterin Level in Psoriatic Patients .
-
CLINICAL_TRIALS study record update · 2022-06-01Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis
-
CLINICAL_TRIALS study record update · 2022-06-01An Open Label, Multicenter Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2022-05-24Diabetes and Psoriasis: Study on Prevalence, Role of Inflammation and Insulin-resistance
-
CLINICAL_TRIALS study record update · 2022-05-23Phase 1, FIH, Randomized, Double-blind, Single-dose, Parallel-group, 3-arm Study Comparing the PK, Safety, Tolerability, and Immunogenicity Profiles of AVT04, EU-approved Stelara®, and US-licensed Stelara® in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2022-04-20Genetic Analysis of Pediatric Psoriasis
-
CLINICAL_TRIALS study record update · 2022-04-13Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate Psoriasis: Retreatment, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study
-
CLINICAL_TRIALS study record update · 2022-04-12A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
-
CLINICAL_TRIALS study record update · 2022-04-11Audiovestibular Manifestations in Patients With Psoriasis
-
CLINICAL_TRIALS study record update · 2022-04-11A Single-center, Open Label Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis